Graphene Investments Sas Jazz Pharmaceuticals PLC Transaction History
Graphene Investments Sas
- $145 Billion
- Q4 2024
A detailed history of Graphene Investments Sas transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Graphene Investments Sas holds 24,200 shares of JAZZ stock, worth $2.99 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
24,200
Previous 27,000
10.37%
Holding current value
$2.99 Million
Previous $3.01 Billion
0.93%
% of portfolio
2.06%
Previous 1.93%
Shares
5 transactions
Others Institutions Holding JAZZ
# of Institutions
510Shares Held
57.6MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$759 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$754 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$308 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$274 Million0.67% of portfolio
-
State Street Corp Boston, MA1.95MShares$240 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.74B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...